- A retrospective analysis finds better survival among black patients with pancreatic ductal adenocarcinoma (PDAC) than white patients when quality of care is similar.
Why this matters
- Black patients should experience better outcomes if access to care is improved.
- Cohort study based on the National Cancer Database (n=278,936; 83.3% white; 12.6% black).
- Funding: None disclosed.
- Black patients were younger at presentation (mean age, 66.2 vs 69.1 years; P<.001 were more likely to have advanced disease stage iii vs p comorbidities comorbidity index score and be treated at an academic or tertiary care center>
- Among stage I patients, black and white patients had similar odds of undergoing surgery, but black patients with stage II disease were less likely to undergo surgery than their white counterparts (52.2% vs 60.2%; P<.001>
- Black patients with advanced disease were less likely to receive chemotherapy, particularly in stage IV (51.0% vs 55.5%; P<.001>
- Black patients had reduced survival (HR, 1.04; 95% CI, 1.02-1.05).
- When controlling for clinical stage and treatment, black patients had better survival (HR, 0.94; 95% CI, 0.93-0.96).
- Retrospective analysis.